COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed the topline data shared today from an open-label study of psilocybin therapy for depression in cancer patients.

Within one week of a single administration of COMP360 psilocybin therapy, 50% of participants achieved remission in depression symptoms, which was sustained for the eight week follow-up period.

More Research Coming!

November 6, 2021 Lynne Nardizzi

Well this is exciting: The DEA has proposed massively increasing the production of research-grade cannabis and psychedelics like LSD, psilocybin, and MDMA next year.

The Role of Drugs in Society

November 5, 2021 Lynne Nardizzi

https://www.youtube.com/watch?v=3LWNY70Oj4A

Carl Hart is a psychologist at Columbia University. Here he talks about heroin, cocaine, MDMA, alcohol & the role of drugs in society.

Interview with Rick Doblin

November 4, 2021 Lynne Nardizzi

Keep reading for an interview with pioneering psychedelic activist Rick Doblin about the promise of MDMA therapy for PTSD, working with Republicans, and his hope for a drug-assisted global spiritual awakening.

The Masks We Wear

October 29, 2021 Lynne Nardizzi

The disguises we wear every day… Hiding your feelings can be freeing. But eventually you have to take off the mask.

Peter Kingsley's Catafalque

October 25, 2021 Lynne Nardizzi

Here’s an enthralling review of Kingsley’s Catafalque.

Ego Dissolution and Psychedelics

October 23, 2021 Lynne Nardizzi

Rethinking the role of the default mode network in psychedelics: dissolving ego dissolution.

Podcast on Psychedelics

October 22, 2021 Lynne Nardizzi

Podcast on psychedelics: the science, research, and medical implications with Dr. Fred Barrett.

Dr. Frederick Barrett is a cognitive neuroscientist with training in behavioral pharmacology. He has been conducting psychedelic research at Johns Hopkins University since 2013. He has explored the effects of psilocybin on the brain, the effects of LSD on the brain’s response to music, and is currently leading a number of ongoing studies aimed at better understanding the psychological, biological, and neural mechanisms underlying the therapeutic efficacy of psychedelic drugs.